Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimen
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference12 articles.
1. Second-line chemotherapy for recurrent carcinoma of the ovary;Thigpen;Cancer,1993
2. Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cisdiamminedichloroplatinum in patients previously responding to this agent;Seltzer;Gynecol Oncol,1985
3. Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapy;Van der Burg;Eur J Cancer,1991
4. Second-line cisplatin (C) treatment (RX) in patients with ovarian cancer (OC) previously treated with cisplatin;Markman,1990
5. Salvage carboplatin therapy for advanced ovarian cancer previously treated with cisplatin;Williams;Am J Clin Oncol,1992
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A risk model of gene signatures for predicting platinum response and survival in ovarian cancer;Journal of Ovarian Research;2022-03-31
2. Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response;Cancer Management and Research;2019-11
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response
3. Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer;Frontiers in Oncology;2019-10-15
4. Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinoma;International Journal of Gynecologic Cancer;2019-09-05
5. Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions;Drug Resistance Updates;2016-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3